All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...692Next →

hiv & aids news selected from other sources

  • Finance and funding
    While HIV aid drops, overall global health spending shows “enduring support”
    Science Speaks | 20 hours ago

    While development assistance to middle and low-income countries for global health reached an all-time high last year, assistance for “the main infectious diseases, HIV/AIDS, tuberculosis, and malaria, contracted on the whole,” according to the Financing Global Health 2013: Transition in an Age of Austerity report published by the Institute of Health Metrics and Evaluation.

  • PrEP
    Singapore Doc: "I remember the very first patient to whom I prescribed PrEP"
    My PrEP Experience (blog) | 20 hours ago

    Many of my patients find it difficult to broach the topic of PrEP. Most of them share with me that they are worried about being judged. I try to assuage this by making the discussion factual, objective, scientific and professional.

  • Microbicides
    Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum
    Eurekalert Medicine & Health | 20 hours ago

    Population Council scientists and their partners have found that their proprietary microbicide gel is safe, stable, and can prevent the transmission of multiple sexually transmitted infections in both the vagina and rectum in animals: HIV, herpes simplex virus 2, and human papillomavirus.

  • Travel
    Government of Mauritius pledges to working towards removing HIV-related restrictions on stay and residence
    UNAIDS (press release) | 20 hours ago

    During a meeting with UNAIDS Executive Director Michel Sidibé in Port Louis on 18 April, Prime Minister of Mauritius Navin Ramgoolam pledged to setting up a special committee to review and make recommendations towards lifting the remaining travel restrictions in the country.

  • PrEP
    Head Of Largest U.S. HIV/AIDS Health Care Organization Still Insists Truvada Is A “Party Drug”
    Buzzfeed | 20 hours ago

    The leader of the nation’s largest community HIV/AIDS health care organization stands by sharp words he had for a drug that has been approved for its potential to prevent the transmission of HIV — comments that some doctors and activists say are “irresponsible” and even led to a petition demanding his resignation.

  • Health services and systems
    Early Data Suggests Many With HIV Accessed Obamacare
    AIDSMeds | 20 hours ago

    A significant proportion of those accessing marketplace insurance plans through Obamacare are people with HIV, according to a study from a major pharmacy benefits manager.

  • Delivery of care
    Motorbikes Speed Up HIV Test Results in Malawi
    Bill & Melinda Gates Foundation (blog) | 20 hours ago

    Improvements to Malawi’s network for transporting laboratory samples will help people living with HIV get vital test results quicker. The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) plans to work with motorcycle couriers Riders for Health to expand the laboratory samples transportation network in Malawi.

  • PrEP
    Medi-Cal Drops Providing Condoms and HIV Testing As Conditions for Prescribing Truvada
    WEHO ville | 21 hours ago

    California’s Medi-Cal program has made it easier for low-income people to get access to Truvada, a drug believed to reduce the risk of contracting HIV, by eliminating requirements that those people be provided with condoms and be tested monthly for HIV and that their doctors seek Medi-Cal’s permission before writing a prescription.

  • Cancer
    Cancer Vaccine Proves Effective in HIV Patients
    New York Times | 21 hours ago

    Vaccines against cervical cancer work well even in sexually active women with H.I.V., a new study has found. It also found that women who already have one or two strains of the cancer-causing virus can be protected against others.

  • Pharmaceutical industry
    Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA
    Gilead press release | 21 hours ago

    Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s refiling of two New Drug Applications (NDA) for cobicistat, a pharmacoenhancing or “boosting” agent that increases blood levels of the protease inhibitors atazanavir and darunavir to enable once-daily dosing of these medicines in HIV therapy, and elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced adults.

← First12345...875Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.